Successful Treatment of Chronic Eosinophilic Pneumonia with Anti-IgE Therapy

다국어 초록 (Multilingual Abstract)

Anti-IgE therapy, using recombinant humanized anti-IgE antibodies, is clinically effective in patients with eosinophil-related disorders such as allergic asthma, allergic rhinitis, and chronic urticaria. Chronic eosinophilic pneumonia tends to respond promptly to systemic corticosteroid therapy, however; relapses are common following corticosteroid tapering.
We treated two patients (17- and 19-yr-old males) of chronic eosinophilic pneumonia whose symptoms were cough and dyspnea on exertion. The symptoms were recurrent while tapering off corticosteroid. They were treated with anti-IgE antibody without recurrence for 2 yr and 15 months. Here, we first describe clinical experience of the 2 cases of chronic eosinophilic pneumonia.

참고문헌 (Reference)

1 Plewako H, "The effect of omalizumab on nasal allergic inflammation" 110 : 68-71, 2002

2 Allen JN, "Eosinophilic lung diseases" 150 : 1423-1438, 1994

3 Djukanovic R, "Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma" 170 : 583-593, 2004

4 남영희, "Effects of Omalizumab Treatment in Patients With Refractory Chronic Urticaria" 대한천식알레르기학회 4 (4): 357-361, 2012

5 Noga O, "Effect of omalizumab treatment on peripheral eosinophil and T-lymphocyte function in patients with allergic asthma" 117 : 1493-1499, 2006

6 Massanari M, "Effect of omalizumab on peripheral blood eosinophilia in allergic asthma" 104 : 188-196, 2010

7 Jederlinic PJ, "Chronic eosinophilic pneumonia. A report of 19 cases and a review of the literature" 67 : 154-162, 1988

8 Naughton M, "Chronic eosinophilic pneumonia. A long-term follow-up of 12 patients" 103 : 162-165, 1993

9 Carrington CB, "Chronic eosinophilic pneumonia" 280 : 787-798, 1969

10 Foroughi S, "Anti-IgE treatment of eosinophilassociated gastrointestinal disorders" 120 : 594-601, 2007